Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy H Chau

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal for Immunotherapy of Cancer|March 5, 2021
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancerRavi A Madan, Fatima Karzai, Renee N Donahue, et al.
Molecular Cancer Research : MCR|April 9, 2017
Differential Expression of OATP1B3 Mediates Unconjugated Testosterone InfluxTristan M Sissung, Ariel M Ley, Jonathan D Strope, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate CancerJessica D Kindrick, Kinjal Bhadresha, Xiaohu Zhang, et al.
Nature Communications|June 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complexYilun Sun, Simone A Baechler, Xiaohu Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal for Immunotherapy of Cancer|March 5, 2021
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancerRavi A Madan, Fatima Karzai, Renee N Donahue, et al.
Molecular Cancer Research : MCR|April 9, 2017
Differential Expression of OATP1B3 Mediates Unconjugated Testosterone InfluxTristan M Sissung, Ariel M Ley, Jonathan D Strope, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate CancerJessica D Kindrick, Kinjal Bhadresha, Xiaohu Zhang, et al.
Nature Communications|June 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complexYilun Sun, Simone A Baechler, Xiaohu Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 8